Genzyme Corporation et al v. Fresenius Kabi USA, LLC
| Genzyme Corporation and Sanofi-Aventis U.S. LLC |
| Fresenius Kabi USA, LLC |
| 1:2018cv01934 |
| December 6, 2018 |
| US District Court for the District of Delaware |
| Kent A Jordan |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on January 23, 2019. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 10 STIPULATION TO EXTEND TIME for Defendant Fresenius Kabi USA, LLC to answer, move or otherwise respond to the Complaint (D.I. 1) to February 27, 2019 - filed by Fresenius Kabi USA, LLC. (Phillips, John) |
SO ORDERED, D.I. #8 Stipulation to Extend Time for Defendant Fresenius Kabi USA, LLC to answer, move or otherwise respond to the Complaint to January 28, 2019 (*Set/Reset Answer Deadlines: Fresenius Kabi USA, LLC answer due 1/28/2019). Ordered by Judge Kent A. Jordan on 12/28/2018. (ceg)
|
|
Filing 9
ORDER: DESIGNATION OF CIRCUIT JUDGE TO HOLD A DISTRICT COURT WITHIN THE CIRCUIT, designating and assigning the Honorable Kent A. Jordan of the United States Court of Appeals for the Third Circuit. Signed by Judge D. Brooks Smith, Chief Judge of the United States Court of Appeals for the Third Circuit on 12/21/18. (rjb)
|
| Case Assigned to Judge Kent A. Jordan. Please include the initials of the Judge (KAJ) after the case number on all documents filed. (rjb) |
| Filing 8 STIPULATION TO EXTEND TIME for Defendant Fresenius Kabi USA, LLC to answer, move or otherwise respond to the Complaint (D.I. 1) to January 28, 2019 - filed by Fresenius Kabi USA, LLC. (Phillips, John) |
| Filing 7 AFFIDAVIT of Service for Declaration of Mailing Pursuant to 10 Del. C. s3104 served on Fresenius Kabi USA, LLC on 12/7/2018, filed by Genzyme Corporation, Sanofi-Aventis U.S. LLC. (Attachments: #1 Exhibit A, #2 Exhibit B)(Bove, Jeffrey) |
| Filing 6 SUMMONS Returned Executed by Sanofi-Aventis U.S. LLC, Genzyme Corporation. Fresenius Kabi USA, LLC served on 12/7/2018, answer due 12/28/2018. (Bove, Jeffrey) |
| Summons Reissued with Magistrate Consent Notice attached as to Fresenius Kabi USA, LLC. (ceg) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Sanofi for Genzyme Corporation, Sanofi-Aventis U.S. LLC filed by Genzyme Corporation, Sanofi-Aventis U.S. LLC. (sar) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 7,897,590 B2 ;US 6,987,102 B2. (sar) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: October 26, 2018. Date of Expiration of Patent: **SEE LIST**.Thirty Month Stay Deadline: 4/26/2021. (sar) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (sar) |
| Filing 1 COMPLAINT FOR PATENT INFRINGEMENT filed against Fresenius Kabi USA, LLC - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2518430.) - filed by Sanofi-Aventis U.S. LLC, Genzyme Corporation. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Civil Cover Sheet)(sar) |
| Summons Issued with Magistrate Consent Notice attached as to Fresenius Kabi USA, LLC on 12/6/2018. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (sar) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
